How Has the Veterinary Assistive Reproduction Technology Market Evolved Historically and What is its Current Size?
The veterinary assistive reproduction technology market has seen considerable growth due to a variety of factors.
• In recent times, there's been substantial growth in the veterinary assistive reproduction technology sector. The market was valued at $3.36 billion in 2024 and is projected to grow to $3.63 billion in 2025, yielding a compound annual growth rate (CAGR) of 7.9%.
Factors such as the preservation and propagation of invaluable genetics, rising demand for animal protein, widespread adoption amongst different animal species, and an enhanced focus on animal health and welfare have largely driven this growth during the historic period.
What Is The Projected Growth Of The Veterinary Assistive Reproduction Technology Template Market?
The veterinary assistive reproduction technology market is expected to maintain its strong growth trajectory in upcoming years.
• The market for veterinary assistive reproduction technology is projected to experience robust expansion in the coming years, reaching a size of $4.88 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%.
The anticipated growth during this period is due to factors such as increasing demand for high-end livestock and pets, a large livestock population, supportive measures, rising investments in animal healthcare, and growing pet ownership. Key trends expected during this period consist of progression in veterinary medicine, improvement in animal reproduction technology, inclusion of artificial insemination (AI), and amplified breeding initiatives.
What Are The Key Drivers Fueling Growth In The Veterinary Assistive Reproduction Technology Market?
The veterinary assistive reproduction technology (VART) market is predicted to grow due to the escalating livestock demand driven by consumers' increased expectations for better taste and nutritional content. This demand is also supplemented by improved breeding technologies which yield animals with attractive characteristics. VART is a key tool in enhancing the breeding efficiency in livestock by supporting fertilization and embryo development, resulting in significant genetic enhancement and productivity boosts. Drawing an example from recent years, the Agriculture and Horticulture Development Board - a UK levy board representing farmers, reported that as per data from December 2023, female cattle over 24 months old experienced a surge by 5,000 units from the last year, hitting a total of 235,000 by August 2024. This uptrend in livestock demand serves as a major driver for the expansion of the veterinary assistive reproduction technology market.
What Are The Principal Market Segments In The Global Veterinary Assistive Reproduction Technology Industry?
The veterinary assistive reproduction technology market covered in this report is segmented –
1) By Type: Services, Semen, Instruments, Kit And Consumables
2) By Animal Type: Bovine, Swine, Ovine, Caprine, Equine, Other Animal Types
3) By Distribution Channel: Private, Public
4) By Technology: Artificial Insemination (AI), In Vitro Fertilization (IVF), Embryo Transfer (MOET), Other Technologies
5) By End-Use: Veterinary Clinics And Hospitals, Animal Breeding Centers, Research Institutes And Universities, Other End-Uses
Subsegments:
1) By Services: Artificial Insemination Services, In Vitro Fertilization (IVF) Services, Embryo Transfer Services, Genetic Testing Services
2) By Semen: Frozen Semen, Fresh Semen, Semen Collection Kits, Semen Processing Services
3) By Instruments: Insemination Cannulas, Embryo Transfer Instruments, Semen Storage Tanks, Ultrasound Machines
4) By Kits and Consumables: Artificial Insemination Kits, Embryo Transfer Kits, Collection and Storage Consumables, Hormonal Treatment Kits
Pre-Book The Veterinary Assistive Reproduction Technology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Veterinary Assistive Reproduction Technology Market?
Leading firms in the veterinary assistive reproduction technology sector are prioritizing the creation of novel products, like superior chelated minerals, to boost the reproductive health of dairy animals. The objective is to amplify reproductive efficiency and bolster the health and productivity of livestock. These advanced chelated minerals aim to elevate levels of fertility and reproductive function in dairy cattle. For example, Rodec Pharma Limited, an Indian producer of veterinary drugs, launched CMIN H8 in July 2023, which is a specially formulated chelated mineral feed designed to enhance reproductive health in dairy animals. This novel product addresses typical reproductive issues in the dairy sector including infertility and other health problems that can decrease productivity. CMIN H8 delivers crucial minerals in a chelated form, augmenting the absorption of these elements and ensuring dairy animals get the best possible support for their reproductive health.
Who Are the Key Players In The Veterinary Assistive Reproduction Technology Market?
Major companies operating in the veterinary assistive reproduction technology market are:
• Zoetis Inc.
• Merck Animal Health
• IDEXX Laboratories Inc.
• Neogen Corporation
• Genus plc
• ABS Global Inc.
• Cryoport Inc.
• Minitube International Inc.
• Semex Alliance
• Select Sires Inc.
• Cogent Breeding Ltd.
• Trans Ova Genetics LLC
• Viking Genetics
• Vytelle Inc.
• Agtech Inc.
• IMV Technologies
• MOFA Global Inc.
• Emlab Genetics
• Avantea Srl
• Alta Genetics Inc.
• Aberekin S.L.
What Are The Regional Insights Into The Veterinary Assistive Reproduction Technology Market?
North America was the largest region in the veterinary assistive reproduction technology market in 2024. The regions covered in the veterinary assistive reproduction technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
